For the details of Polaris Venture Management Co. V, L.L.C.'s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=Polaris+Venture+Management+Co.+V%2C+L.L.C.
These are the top 5 holdings of Polaris Venture Management Co. V, L.L.C.- Cardlytics Inc (CDLX) - 2,636,262 shares, 31.26% of the total portfolio.
- Fate Therapeutics Inc (FATE) - 2,473,186 shares, 15.28% of the total portfolio.
- Kala Pharmaceuticals Inc (KALA) - 1,857,582 shares, 13.9% of the total portfolio.
- Neuronetics Inc (STIM) - 824,765 shares, 11.96% of the total portfolio. New Position
- Selecta Biosciences Inc (SELB) - 1,606,813 shares, 11.6% of the total portfolio.
Polaris Venture Management Co. V, L.L.C. initiated holding in Neuronetics Inc. The purchase prices were between $26.61 and $27.78, with an estimated average price of $27.2. The stock is now traded at around $34.95. The impact to a portfolio due to this purchase was 11.96%. The holding were 824,765 shares as of 2018-06-30.
Added: Pulmatrix Inc (PULM)Polaris Venture Management Co. V, L.L.C. added to a holding in Pulmatrix Inc by 28.54%. The purchase prices were between $0.43 and $0.6, with an estimated average price of $0.49. The stock is now traded at around $0.37. The impact to a portfolio due to this purchase was 0.2%. The holding were 3,594,381 shares as of 2018-06-30.
Here is the complete portfolio of Polaris Venture Management Co. V, L.L.C.. Also check out:
1. Polaris Venture Management Co. V, L.L.C.'s Undervalued Stocks
2. Polaris Venture Management Co. V, L.L.C.'s Top Growth Companies, and
3. Polaris Venture Management Co. V, L.L.C.'s High Yield stocks
4. Stocks that Polaris Venture Management Co. V, L.L.C. keeps buying
